The Natural Compound Oblongifolin C Exhibits Anticancer Activity by Inhibiting HSPA8 and Cathepsin B In Vitro.
The Natural Compound Oblongifolin C Exhibits Anticancer Activity by Inhibiting HSPA8 and Cathepsin B In Vitro.
复制标题
天然化合物 Oblongifolin C 通过在体外抑制 HSPA8 和组织蛋白酶 B 表现出抗癌活性。
DOI:
10.3389/fphar.2020.564833
复制
发表时间:
2020
影响因子:
5.6
通讯作者:
Xu H
中科院分区:
文献类型:
--
作者:
Han L;Xu D;Xi Z;Wu M;Nik Nabil WN;Zhang J;Sui H;Fu W;Zhou H;Lao Y;Xu G;Guo C;Xu H
PPAPs (Polycyclic polyprenylated acylphloroglucinols) are a class of compounds with diverse bioactivities, including anticancer effects. Oblongifolin C (OC) is a PPAP isolated from the plant of Garcinia yunnanensis Hu. We previously discovered that OC induces apoptosis, inhibits autophagic flux, and attenuates metastasis in cancer cells. However, the protein targets and the detailed mechanism of action of OC remain unclear. To identify protein targets of OC, a non-labeled protein fishing assay was performed, and it was found that OC may interact with several proteins, including the heat shock 70 kDa protein 8 (HSPA8). Expanding on our previous studies on protein cathepsin B, this current study applied Surface Plasmon Resonance (SPR) and Isothermal Titration Calorimetry (ITC) to confirm the potential binding affinity between OC and two protein targets. This study highlights the inhibitory effect of OC on HSPA8 in cancer cells under heat shock stress, by specifically inhibiting the translocation of HSPA8. OC also enhanced the interaction between HSPA8, HSP90, and p53, upregulated the expression of p53 and significantly promoted apoptosis in cisplatin-treated cells. Additionally, a flow cytometry assay detected that OC sped up the apoptosis rate in HSPA8 knockdown A549 cells, while overexpression of HSPA8 delayed the OC-induced apoptosis rate. In summary, our results reveal that OC potentially interacts with HSPA8 and cathepsin B and inhibits HSPA8 nuclear translocation and cathepsin B activities, altogether suggesting the potential of OC to be developed as an anticancer drug.
登录
查看更多内容
影响因子:
7.5
作者:
Hämälistö S;Jäättelä M
通讯作者:
Jäättelä M
DOI:
10.1002/prca.201300105
发表时间:
2014-06
期刊:
Proteomics. Clinical applications
影响因子:
--
作者:
Aggarwal N;Sloane BF
通讯作者:
Sloane BF
DOI:
10.1158/1541-7786.mcr-11-0019
发表时间:
2011-07
期刊:
Molecular cancer research : MCR
影响因子:
--
作者:
Leu JI;Pimkina J;Pandey P;Murphy ME;George DL
通讯作者:
George DL
影响因子:
3.6
作者:
Budina-Kolomets, Anna;Balaburski, Gregor M.;Murphy, Maureen E.
通讯作者:
Murphy, Maureen E.
影响因子:
2.9
作者:
Andreotti G;Monticelli M;Cubellis MV
通讯作者:
Cubellis MV